1. Home
  2. PBT vs HUMA Comparison

PBT vs HUMA Comparison

Compare PBT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBT
  • HUMA
  • Stock Information
  • Founded
  • PBT 1980
  • HUMA 2004
  • Country
  • PBT United States
  • HUMA United States
  • Employees
  • PBT N/A
  • HUMA N/A
  • Industry
  • PBT Oil & Gas Production
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBT Energy
  • HUMA Health Care
  • Exchange
  • PBT Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • PBT 558.4M
  • HUMA 584.8M
  • IPO Year
  • PBT N/A
  • HUMA N/A
  • Fundamental
  • Price
  • PBT $11.10
  • HUMA $4.37
  • Analyst Decision
  • PBT
  • HUMA Strong Buy
  • Analyst Count
  • PBT 0
  • HUMA 7
  • Target Price
  • PBT N/A
  • HUMA $13.43
  • AVG Volume (30 Days)
  • PBT 116.9K
  • HUMA 2.4M
  • Earning Date
  • PBT 01-01-0001
  • HUMA 03-21-2025
  • Dividend Yield
  • PBT 4.81%
  • HUMA N/A
  • EPS Growth
  • PBT 25.21
  • HUMA N/A
  • EPS
  • PBT 0.78
  • HUMA N/A
  • Revenue
  • PBT $37,735,284.00
  • HUMA N/A
  • Revenue This Year
  • PBT N/A
  • HUMA N/A
  • Revenue Next Year
  • PBT N/A
  • HUMA $4,344.68
  • P/E Ratio
  • PBT $14.14
  • HUMA N/A
  • Revenue Growth
  • PBT 25.46
  • HUMA N/A
  • 52 Week Low
  • PBT $10.14
  • HUMA $2.81
  • 52 Week High
  • PBT $14.58
  • HUMA $9.97
  • Technical
  • Relative Strength Index (RSI)
  • PBT 39.41
  • HUMA 45.11
  • Support Level
  • PBT $10.95
  • HUMA $4.20
  • Resistance Level
  • PBT $11.41
  • HUMA $4.78
  • Average True Range (ATR)
  • PBT 0.42
  • HUMA 0.28
  • MACD
  • PBT -0.06
  • HUMA -0.02
  • Stochastic Oscillator
  • PBT 15.05
  • HUMA 42.17

About PBT Permian Basin Royalty Trust

Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Share on Social Networks: